Sri Sai Subramanyam Challa. EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES. J Popl Ther Clin Pharmacol [Internet]. 2021 Aug. 25 [cited 2025 Oct. 8];28(2):436-48. Available from: https://www.jptcp.com/index.php/jptcp/article/view/7421